Enteric conversion after pancreatic transplantation: resolution of symptoms and long-term results

Kleespies A, Mikhailov M, Khalil PN, Preissler G, Rentsch M, Arbogast H, Illner W‐D, Bruns CJ, Jauch K‐W, Angele MK. Enteric conversion after pancreatic transplantation: resolution of symptoms and long‐term results.
Clin Transplant 2011: 25: 549–560. © 2010 John Wiley & Sons A/S. :  Purpose:  Bl...

Full description

Saved in:
Bibliographic Details
Published inClinical transplantation Vol. 25; no. 4; pp. 549 - 560
Main Authors Kleespies, Axel, Mikhailov, Michael, Khalil, Philipe N., Preissler, Gerhard, Rentsch, Markus, Arbogast, Helmut, Illner, Wolf-Dieter, Bruns, Christiane J., Jauch, Karl-Walter, Angele, Martin K.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.07.2011
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Kleespies A, Mikhailov M, Khalil PN, Preissler G, Rentsch M, Arbogast H, Illner W‐D, Bruns CJ, Jauch K‐W, Angele MK. Enteric conversion after pancreatic transplantation: resolution of symptoms and long‐term results.
Clin Transplant 2011: 25: 549–560. © 2010 John Wiley & Sons A/S. :  Purpose:  Bladder drainage (BD) of pancreatic transplants is associated with a unique set of complications. We intended to analyze the incidence, indications, complications and long‐term results of enteric conversion procedures (EC). Methods:  Using a prospective database, 32 EC patients out of 433 simultaneous pancreas–kidney‐transplant (SPK) recipients were identified. Graft and patient survival rates were compared with those after primary enteric drainage (ED). Results:  The mean SPK‐EC interval was 5.0 yr, and the mean patient follow‐up was 13.8 yr. Indications for EC were genitourinary symptoms (62.5%), duodenal complications (15.6%), graft pancreatitis (12.5%), pyelonephritis (6.3%), and metabolic acidosis (3.1%). All patients reported significant long‐term resolution of symptoms. Surgical complications, reoperations, early graft loss, and 30‐d mortality occurred in 31.3%, 25.0%, 6.3%, and 3.1% of cases, respectively. Pancreatic graft and patient survival rates at 1, 5, and 10 yr after SPK were comparable between EC patients and ED patients at the same institution. Conclusion:  For the treatment of symptoms associated with BD, EC results in excellent long‐term graft function and significant resolution of symptoms even years after SPK. Postoperative morbidity after EC including early reoperation and graft loss, however, has to be considered.
Bibliography:ArticleID:CTR1363
istex:91E32E78D2073126C4E8C70657F4976D58650AD2
ark:/67375/WNG-9XF565R5-F
Conflict of interest: None.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0902-0063
1399-0012
DOI:10.1111/j.1399-0012.2010.01363.x